Skip to main content
Sakar Healthcare Limited logo

Sakar Healthcare Limited — Investor Relations & Filings

Ticker · SAKAR ISIN · INE732S01012 LEI · 984500DCC013A08BA460 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 500 across all filing types
Latest filing 2026-05-22 Call Transcript
Country IN India
Listing National Stock Exchange of India SAKAR

About Sakar Healthcare Limited

https://www.sakarhealthcare.com

Sakar Healthcare Limited is a pharmaceutical manufacturing organization specializing in the development and production of a diverse range of therapeutic formulations. The company operates advanced manufacturing facilities, including a dedicated oncology unit and WHO-GMP certified plants for general oral solids, liquid orals, and cephalosporin products. Its product portfolio encompasses tablets, capsules, liquid orals, and small volume parenterals across various therapeutic segments. Sakar Healthcare provides comprehensive contract manufacturing and research services (CRAMS) to global pharmaceutical entities. The company maintains a strong focus on quality compliance and research-driven development, catering to both domestic and regulated international markets. Key capabilities include the production of specialized anti-cancer medications and complex injectable formulations, supported by integrated research and development laboratories.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 92% confidence The document is a disclosure under Regulation 30 of the SEBI Listing Obligations, providing the full text of the Q4 FY26 Earnings Conference Call transcript (including management remarks, financial results, and Q&A). It clearly contains the complete call transcript rather than merely announcing or linking to it. Therefore, it should be classified as a Call Transcript.
2026-05-22 English
General Updates
Regulatory Filings Classification · 78% confidence The document is a notice to the stock exchange’s Listing Compliance Department announcing a new commercial agreement and providing a business and regulatory update. It contains no financial statements or earnings figures, nor is it an earnings release or formal report; it simply discloses material business developments to regulators. This aligns with a general regulatory announcement, placing it in the fallback category of Regulatory Filings (RNS).
2026-05-21 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 90% confidence The document is a statutory disclosure under SEBI (Substantial Acquisition of Shares and Takeover) Regulations regarding encumbrances by promoters. It does not provide financial statements, announce a meeting result, or report changes in shareholding thresholds; instead, it is a regulatory compliance filing that does not fit into other specific categories. Therefore, it is classified as a general Regulatory Filing (RNS).
2026-05-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Report Publication Announcement Classification · 85% confidence The document is a short notice to the stock exchange under SEBI Regulation 30 announcing that the audio recording of the Q4FY26 conference call (and a forthcoming transcript) has been made available on the company website. It does not contain the actual call transcript or substantive financial data. This fits the definition of a Report Publication Announcement (RPA): a brief notice announcing the availability of a report or recording rather than the report itself.
2026-05-16 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is a formal disclosure under SEBI LODR Regulation 30, attaching the full slide deck titled “Investor Presentation | Q4 FY26.” It contains detailed slides on company overview, strategy, board, business segments, and audited financial results for the quarter/year ended March 31, 2026. This matches the definition of an Investor Presentation (IP), not merely an announcement of a report or a regulatory filing.
2026-05-13 English
Press Release
Earnings Release Classification · 88% confidence The document is a press release announcing consolidated and standalone audited financial results for Q4 and FY26, providing high-level financial highlights, YoY growth percentages, EBITDA, PAT figures, business commentary, and a Safe Harbor statement. It does not contain full audited financial statements or detailed disclosures as an annual or interim report, nor is it a mere publication notice. This aligns with an Earnings Release. FY 2026
2026-05-13 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.